Context Therapeutics Inc
NASDAQ:CNTX

Watchlist Manager
Context Therapeutics Inc Logo
Context Therapeutics Inc
NASDAQ:CNTX
Watchlist
Price: 1.3 USD 7.44%
Market Cap: 119.4m USD

Intrinsic Value

CNTX doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of CNTX.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CNTX Intrinsic Value
Not Available
Base Case Scenario
Compare CNTX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CNTX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Context Therapeutics Inc

Current Assets 79m
Cash & Short-Term Investments 76.9m
Other Current Assets 2.1m
Current Liabilities 6m
Accounts Payable 2.7m
Accrued Liabilities 3.3m
Other Current Liabilities 40k
Non-Current Liabilities 20k
Other Non-Current Liabilities 20k
Efficiency

Free Cash Flow Analysis
Context Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Context Therapeutics Inc

Revenue
0 USD
Operating Expenses
-30.6m USD
Operating Income
-30.6m USD
Other Expenses
4.2m USD
Net Income
-26.4m USD
Fundamental Scores

CNTX Profitability Score
Profitability Due Diligence

Context Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Context Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CNTX Solvency Score
Solvency Due Diligence

Context Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Context Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CNTX Price Targets Summary
Context Therapeutics Inc

Wall Street analysts forecast CNTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CNTX is 5.44 USD with a low forecast of 4.04 USD and a high forecast of 9.45 USD.

Lowest
Price Target
4.04 USD
211% Upside
Average
Price Target
5.44 USD
318% Upside
Highest
Price Target
9.45 USD
627% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Context Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CNTX is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CNTX Insider Trading
Buy and sell transactions by insiders